Khaled, Hussein
Gamal, Heba
Lotayef, Mohamed
Knauer, Michael
Thürliman, Beat
Article History
Received: 23 August 2018
Accepted: 25 August 2018
First Online: 14 September 2018
Compliance with ethical standards
:
: Hussein Khaled declares that he has no conflict of interest; Heba Gamal declares that she has no conflict of interest; Mohamed Lotayef declares that he has no conflict of interest; Michael Knauel declares that he has no conflict of interest; Beat Thürliman has consultant/advisory role for Amgen, Astra Zeneca, Eli Lilly, Pfizer, and stock ownership in Novartis, and Roche Pharmaceutical companies.
: This article does not contain any studies with human participants performed by any of the authors.